Celcuity Inc.
NASDAQ:CELCBiotechnology
-$4.04 today
- Market cap
- $2.72B
- Beta
- 0.12
- P/E (TTM)
- -23.7
- EPS (TTM)
- -$3.54
Volume 0.98M
Average 1.24M
CELC Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Celcuity Inc.NASDAQ: CELC
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue remains negative
Q2 FY2026 cost of revenue was $0, compared with $0 a year earlier. Trailing-twelve-month cost of revenue was $47K.
Context
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly cost of revenue holds near $0 or moves back toward the trailing-twelve-month quarterly average of $11.75K.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 167K USD
- Year-over-year change
- —
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 167K | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Cost of Revenue vs competitors
How CELC compares with its peers on the latest reported figures
- CELC's LTM Jun 2026 cost of revenue of $47K is the lowest of the 6 companies compared; the peer median is $77.95M.
- Its year-over-year change of +33.3% is the 2nd highest of 6, against a peer median of +13.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $437.4M | +13.2% | +11.4% | 57.1% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $114.19M | +39.8% | — | 28.7% |
| LTM Mar 2026 | $77.95M | +24.3% | +30.4% | 22.9% | |
| LTM Jun 2026 | $75.68M | +8.6% | +7.2% | 24.6% | |
| LTM Mar 2026 | $55.67M | -2.6% | +1.4% | 86.3% | |
| LTM Jun 2026 | $47K | +33.3% | — | — | |
| Peer median (excluding CELC) | $77.95M | +13.2% | +9.3% | 28.7% | |
Competitors are the stored peer set for CELC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 167K |
| Gross Profit | 0 | 0 | 0 | 0 | (167K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 25.76M | 35.29M | 60.59M | 104.2M | 145M |
| Selling, General & Admin | 2.6M | 4.38M | 5.64M | 9.06M | 27.2M |
| Operating Expenses | 28.36M | 39.39M | 66.23M | 113.27M | 172.19M |
| Depreciation & Amortization | 303.24K | 210.92K | 142.77K | 129.95K | 167K |
| EBITDA | (28.04M) | (38.05M) | (58.31M) | (101.37M) | (159.73M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (28.36M) | (39.39M) | (66.23M) | (113.27M) | (172.19M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 13.26K | 1.13M | 7.78M | 11.77M | 12.3M |
| Interest Expense | 1.26M | 2.11M | 5.33M | 10.28M | 17.15M |
| Other Income / Expenses | (1.25M) | (978.95K) | 2.45M | 1.49M | (4.85M) |
| Income Before Tax | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| EPS (Diluted) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| Weighted Avg Shares | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
| Weighted Avg Shares (Diluted) | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
Celcuity Inc.
NASDAQ:CELC
Intrinsic Alpha fair value
Locked
Current Price
$55.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.